Update on HLA-B*15:02 allele associated with adverse drug reactions

被引:0
作者
Zhu, Xueting [1 ]
Luo, Guanghua [1 ]
Zheng, Lu [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Clin Med Res Ctr, Changzhou, Peoples R China
关键词
adverse drug reactions; antiepileptic drug; genetic marker; HLA-B*15:02; review; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; POLYMERASE-CHAIN-REACTION; HLA CLASS-I; INDUCED MACULOPAPULAR EXANTHEMA; GENETIC-MARKERS; RISK-FACTOR; B LOCUS; CARBAMAZEPINE; HAN;
D O I
10.2217/pgs-2023-0173
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
HLA alleles, part of the major histocompatibility complex, are strongly associated with adverse drug reactions (ADRs). This review focuses on HLA-B*15:02 and explores its association with ADRs in various ethnic populations and with different drugs, aiming to provide insights into the safe clinical use of drugs and minimize the occurrence of ADRs. Furthermore, the review explores the potential mechanisms by which HLA-B*15:02 may be associated with ADRs, aiming to gain new insights into drug modification and identification of haptens. In addition, it analyzes the frequency of the HLA-B*15:02, genotyping methods, cost-effectiveness and treatment measures for adverse reactions, thereby providing a theoretical basis for formulating clinical treatment plans.
引用
收藏
页码:97 / 111
页数:15
相关论文
共 50 条
  • [31] HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature
    Liao, Jin-Mao
    Zhan, Yan
    Zhang, Zheng
    Cui, Jia-Jia
    Yin, Ji-Ye
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [32] A study of HLA-B*15:02 in a Sri Lankan population: Implications for pharmacogenomic testing
    Gunathilake, K. M. D.
    Wettasinghe, K. T.
    Dissanayake, V. H. W.
    HUMAN IMMUNOLOGY, 2016, 77 (05) : 429 - 431
  • [33] HLA-B allele frequencies and implications for pharmacogenetics in the Kuwaiti population
    Dashti, Mohammed
    Malik, Md Zubbair
    Al-Matrouk, Abdullah
    Bhatti, Saeeda
    Nizam, Rasheeba
    Jacob, Sindhu
    Al-Mulla, Fahd
    Thanaraj, Thangavel Alphonse
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [34] Cost-effectiveness of HLA-B*15:02 screening in Malaysia
    Plumpton, C.
    Hughes, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (04) : 904 - 905
  • [35] Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
    Amstutz, Ursula
    Shear, Neil H.
    Rieder, Michael J.
    Hwang, Soomi
    Fung, Vincent
    Nakamura, Hidefumi
    Connolly, Mary B.
    Ito, Shinya
    Carleton, Bruce C.
    EPILEPSIA, 2014, 55 (04) : 496 - 506
  • [36] An interdigitated electrode biosensor platform for rapid HLA-B*15:02 genotyping for prevention of drug hypersensitivity
    Soraya, Gita V.
    Chan, Jianxiong
    Nguyen, Thanh C.
    Huynh, Duc H.
    Abeyrathne, Chathurika D.
    Chana, Gursharan
    Todaro, Marian
    Skafidas, Efstratios
    Kwan, Patrick
    BIOSENSORS & BIOELECTRONICS, 2018, 111 : 174 - 183
  • [37] Development of a HLA-B*58:01 Allele Screening System for Allopurinol-Induced Severe Cutaneous Adverse Reactions Detection
    Gan, Kok Beng
    Chong, Kim Soon
    Nawoor, Anusha Devi
    Then, Sue-Mian
    Abdul Murad, Nor Azian
    A. Jamal, A. Rahman
    IEEE ACCESS, 2020, 8 (08) : 225306 - 225323
  • [38] Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and Phenytoin-Induced Cutaneous Adverse Drug Reactions in the South Indian Tamil Population
    John, Shobana
    Balakrishnan, Karuppiah
    Sukasem, Chonlaphat
    Anand, Tharmarajan Chinnathambi Vijay
    Canyuk, Bhutorn
    Pattharachayakul, Sutthiporn
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [39] Impact of the HLA-B*58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions
    Ng, Chau Yee
    Yeh, Yu-Ting
    Wang, Chuang-Wei
    Hung, Shuen-Iu
    Yang, Chih-Hsun
    Chang, Ya-Ching
    Chang, Wan-Chun
    Lin, Yu-Jr
    Chang, Chee-Jen
    Su, Shih-Chi
    Fan, Wen-Lang
    Chen, Der-Yuan
    Wu, Yeong-Jian Jan
    Tian, Ya-Chung
    Hui, Rosaline Chung-Yee
    Chung, Wen-Hung
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (07) : 1373 - 1381
  • [40] Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies
    Wu, Ran
    Cheng, Yi-ju
    Zhu, Li-li
    Yu, Lei
    Zhao, Xue-ke
    Jia, Min
    Wen, Chang-hui
    Long, Xing-zhen
    Tang, Ting
    He, Ai-juan
    Zeng, Yi-yan
    Ma, Zun-feng
    Zheng, Zhi
    Ni, Mu-zi
    Cai, Gong-jing
    ONCOTARGET, 2016, 7 (49) : 81870 - 81879